Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does MEDROXYPROGESTERONE Cause Gait disturbance? 39 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 39 reports of Gait disturbance have been filed in association with MEDROXYPROGESTERONE (Provera). This represents 0.5% of all adverse event reports for MEDROXYPROGESTERONE.

39
Reports of Gait disturbance with MEDROXYPROGESTERONE
0.5%
of all MEDROXYPROGESTERONE reports
0
Deaths
15
Hospitalizations

How Dangerous Is Gait disturbance From MEDROXYPROGESTERONE?

Of the 39 reports, 15 (38.5%) required hospitalization, and 5 (12.8%) were considered life-threatening.

Is Gait disturbance Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for MEDROXYPROGESTERONE. However, 39 reports have been filed with the FAERS database.

What Other Side Effects Does MEDROXYPROGESTERONE Cause?

Meningioma (1,364) Drug dose omission by device (510) Device leakage (500) Incorrect dose administered by device (410) Drug ineffective (403) Off label use (390) Syringe issue (354) Needle issue (346) Headache (288) Device occlusion (284)

What Other Drugs Cause Gait disturbance?

DALFAMPRIDINE (8,780) ADALIMUMAB (8,714) ETANERCEPT (6,505) METHOTREXATE (5,141) TOFACITINIB (3,878) PREGABALIN (3,590) DIMETHYL (3,434) SECUKINUMAB (3,222) ABATACEPT (3,110) LEFLUNOMIDE (3,041)

Which MEDROXYPROGESTERONE Alternatives Have Lower Gait disturbance Risk?

MEDROXYPROGESTERONE vs MEDROXYPROGESTERONE\MEDROXYPROGESTERONE MEDROXYPROGESTERONE vs MEFENAMIC ACID MEDROXYPROGESTERONE vs MEFLOQUINE MEDROXYPROGESTERONE vs MEGESTROL MEDROXYPROGESTERONE vs MEGLUMINE

Related Pages

MEDROXYPROGESTERONE Full Profile All Gait disturbance Reports All Drugs Causing Gait disturbance MEDROXYPROGESTERONE Demographics